The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
Publication number:
EP3311170
WO Application Number:
EP2015074527
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP15784368.1
WO Publication Number:
WO2016202414
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Belgium (BE)
Publications:
Dates
Filing date:
22/10/2015
Grant date:
13/10/2021
EP Publication Date:
25/04/2018
WO Publication Date:
22/12/2016
Claims Translations Received Date:
Claims Translation B1 Received Date:
11/11/2021
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
13/10/2021
EP B1 Publication Date:
13/10/2021
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
21/10/2035
Lapsed By Expiration Date:
Patent Validated Date:
14/12/2021
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
13/10/2021
Name:
UCB Biopharma SRL
Address:
Allé de la Recherche 60, 1070 Brussels, Belgium (BE)
Agent
Name:
ir. M.F.J.M. Ketelaars c.s.
From:
10/12/2021
Address:
NLO
Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)